Earnings estimate | Current qtr. (Dec 2018) | Next qtr. (Mar 2019) | Current year (2018) | Next year (2019) |
---|---|---|---|---|
No. of analysts | 0 | 0 | 0 | 0 |
Avg. Estimate | 0 | 0 | 0 | 0 |
Low estimate | 0 | 0 | 0 | 0 |
High estimate | 0 | 0 | 0 | 0 |
Year ago EPS | 1.7 | 1.37 | N/A | N/A |
Revenue estimate | Current qtr. (Dec 2018) | Next qtr. (Mar 2019) | Current year (2018) | Next year (2019) |
---|---|---|---|---|
No. of analysts | 2 | 0 | 19 | 19 |
Avg. Estimate | 30.18B | N/A | 114.58B | 124.97B |
Low estimate | 29.84B | N/A | 110.88B | 119.29B |
High estimate | 30.53B | N/A | 118.1B | 130.82B |
Year ago sales | 27.13B | N/A | 104.47B | 114.58B |
Sales growth (year/est) | 11.30% | N/A | 9.70% | 9.10% |
Earnings history | 31/12/2017 | 31/03/2018 | 30/06/2018 | 30/09/2018 |
---|---|---|---|---|
Est. EPS | 1.7 | 1.78 | 1.64 | 1.52 |
Actual EPS | 1.7 | 1.37 | 2.51 | 0.9 |
Difference | 0 | -0.41 | 0.87 | -0.62 |
Surprise % | 0.00% | -23.00% | 53.00% | -40.80% |
EPS trend | Current qtr. (Dec 2018) | Next qtr. (Mar 2019) | Current year (2018) | Next year (2019) |
---|---|---|---|---|
Current estimate | 0 | 0 | 0 | 0 |
7 days ago | 1.17 | 2.3 | 6.98 | 8.28 |
30 days ago | 1.17 | 2.3 | 6.98 | 8.28 |
60 days ago | 1.17 | 2.3 | 6.98 | 8.28 |
90 days ago | 1.17 | 2.3 | 6.98 | 8.28 |
EPS revisions | Current qtr. (Dec 2018) | Next qtr. (Mar 2019) | Current year (2018) | Next year (2019) |
---|---|---|---|---|
Up last 7 days | N/A | N/A | N/A | N/A |
Up last 30 days | N/A | N/A | N/A | N/A |
Down last 7 days | N/A | N/A | N/A | N/A |
Down last 30 days | N/A | N/A | N/A | N/A |
Growth estimates | AMBUJACEM.BO | Industry | Sector(s) | S&P 500 |
---|---|---|---|---|
Current qtr. | N/A | N/A | N/A | N/A |
Next qtr. | N/A | N/A | N/A | N/A |
Current year | N/A | N/A | N/A | N/A |
Next year | N/A | N/A | N/A | N/A |
Next 5 years (per annum) | -5.30% | N/A | N/A | N/A |
Past 5 years (per annum) | N/A | N/A | N/A | N/A |